Management of New-Onset Postoperative Atrial Fibrillation (Monitor-AF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01395836|
Recruitment Status : Completed
First Posted : July 18, 2011
Last Update Posted : November 4, 2016
|Condition or disease|
|Atrial Fibrillation Coronary Artery Disease Post Operative Arrythmia|
|Study Type :||Observational|
|Actual Enrollment :||23 participants|
|Official Title:||Management of New-Onset Postoperative Atrial Fibrillation Utilizing Insertable Cardiac Monitor Technology to Observe Recurrence of AF|
|Study Start Date :||October 2011|
|Actual Primary Completion Date :||March 2016|
|Actual Study Completion Date :||March 2016|
The "treatment" group will be medically managed based on data obtained from monthly transmissions of the implanted Cardiac Monitor.
The "control" group will be managed in the usual standard of care with physicians blinded to their ICM data.
- The presence of AF at any post-operative points in time. [ Time Frame: 3 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01395836
|United States, Georgia|
|Emory University Hospital Midtown|
|Atlanta, Georgia, United States, 30308|
|Principal Investigator:||Mikhael F El Chami, MD||Emory University|